Imaging Vulnerable Plaque by Ultrasound
Anthony N. DeMaria, MD, MACC*,a,*,
Jagat Narula, MD, PhD, FACC ,
Ehtisham Mahmud, MD, FACC* and
Sotirios Tsimikas, MD, FACC*
* Division of Cardiology, University of California San Diego, San Diego, California, USA
Division of Cardiology, University of California-Irvine School of Medicine, Irvine, California, USA
Manuscript received June 16, 2005;
revised manuscript received November 2, 2005,
accepted November 8, 2005.
* Reprint requests and correspondence: Dr. Anthony N. DeMaria, Cardiology Division, UCSD Medical Center, 200 West Arbor Drive, San Diego, California 92103-8411 (Email: ademaria{at}ucsd.edu).
Diagnostic techniques to identify vulnerable plaques are rapidly evolving. Intravascular ultrasound (IVUS) has the ability to detect and localize plaque as well as quantitate plaque burden. Recent IVUS studies have suggested that patients presenting with acute coronary syndromes have an approximate 25% incidence of additional ruptured plaques in arteries other than the culprit lesion. The ability of IVUS to detect vulnerable plaques before rupture is currently being evaluated by novel techniques. Initially, IVUS was shown to be able to characterize plaque broadly as calcified or fibrofatty but was limited in its ability to more precisely detect lipid-rich plaques, necrotic cores, and thrombus. Recent advances in new applications of IVUS, such as integrated backscatter, wavelet analysis, and virtual histology, have focused on evaluating and mathematically transforming the radiofrequency signal from ultrasound waves into a color-coded representation of plaque characteristics such as lipid, fibrous tissue, calcification, and necrotic core. In addition, targeted contrast agents, applicable to both intravascular and transthoracic studies, are being evaluated in experimental models and aim to highlight specific plaque components, such as endothelial adhesion molecules and other plaque components that might be useful in targeting vulnerable plaques. These advances pave the way for future clinical trials in assessing the ability of such techniques to diagnose vulnerable plaques and to assess the effects of both pharmacologic and mechanical therapies on plaque characteristics.
|
Abbreviations and Acronyms
| | 3D-IB-IVUS = three-dimensional intravascular ultrasound with integrated back scatter | | ACS = acute coronary syndromes | | ICAM = intracellular adhesion molecules | | IVUS = intravascular ultrasound | | PS = phosphatidylserine | | RF = radiofrequency |
|
This article has been cited by other articles:
|
|
|
|
 
D. Vancraeynest, A. Pasquet, V. Roelants, B. L. Gerber, and J.-L. J. Vanoverschelde
Imaging the Vulnerable Plaque
J. Am. Coll. Cardiol.,
May 17, 2011;
57(20):
1961 - 1979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. L. Schinkel, C. G. Krueger, A. Tellez, J. F. Granada, J. D. Reed, A. Hall, W. Zang, C. Owens, G. L. Kaluza, D. Staub, et al.
Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis
Eur Heart J Cardiovasc Imaging,
September 1, 2010;
11(8):
659 - 664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Edgeworth, J. A. Ross, T. Anderson, M. Butler, W. N. McDicken, and C. Moran
Novel flow chamber to investigate binding strength of a lipid-based, high-frequency, ultrasonic contrast agent
Ultrasound,
August 1, 2010;
18(3):
130 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Philipp, D. Bose, W. Wijns, S. P. Marso, R. S. Schwartz, A. Konig, A. Lerman, H. M. Garcia-Garcia, P. W. Serruys, and R. Erbel
Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry
Eur. Heart J.,
January 2, 2010;
31(2):
196 - 202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O C Raffel, T Akasaka, and I-K Jang
Cardiac optical coherence tomography
Heart,
September 1, 2008;
94(9):
1200 - 1210.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alfonso and L. Hernando
Intravascular ultrasound tissue characterization. I like the rainbow but... what's behind the colours?
Eur. Heart J.,
July 2, 2008;
29(14):
1701 - 1703.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Kern and J. Narula
Looking into the vessel: the more you see, the more you want to see.
J. Am. Coll. Cardiol. Img.,
July 1, 2008;
1(4):
556 - 559.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. Cheruvu, A. V. Finn, C. Gardner, J. Caplan, J. Goldstein, G. W. Stone, R. Virmani, and J. E. Muller
Frequency and Distribution of Thin-Cap Fibroatheroma and Ruptured Plaques in Human Coronary Arteries: A Pathologic Study
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
940 - 949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bose, C. von Birgelen, and R. Erbel
Intravascular Ultrasound for the Evaluation of Therapies Targeting Coronary Atherosclerosis
J. Am. Coll. Cardiol.,
March 6, 2007;
49(9):
925 - 932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Waxman, F. Ishibashi, and J. E. Muller
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
Circulation,
November 28, 2006;
114(22):
2390 - 2411.
[Full Text]
[PDF]
|
|
|
|
